Skip to main content
The William Harvey Research Institute - Faculty of Medicine and Dentistry

Professor Costantino Pitzalis receives prestigious American College of Rheumatology honour

Professor Costantino Pitzalis from Queen Mary University of London's William Harvey Research Institute (WHRI) has been awarded the title of Master of the American College of Rheumatology (MACR) for 2026.

Published:

Professor Costantino Pitzalis with his award at the 2026 American College of Rheumatology (ACR) meeting.

The award recognises members who have made significant contributions to rheumatology through their research, clinical work, teaching and service to the field.

Professor Pitzalis is Professor of Experimental Medicine and Rheumatology at Queen Mary and leads research at the Centre for Experimental Medicine and Rheumatology within WHRI. His work focuses on understanding the causes and progression of rheumatoid arthritis, with the aim of improving how the condition is diagnosed and treated.

Speaking about the award, Professor Pitzalis said:

"Receiving the ACR Master designation is a deeply humbling honour, reflecting a lifetime dedicated to advancing rheumatology through research, education and patient care. It reaffirms my commitment to translating discovery science into clinical innovation, improving patient care through the integration of molecular pathology into clinical management algorithms, and inspiring the next generation of translational clinicians and scientists."

Research presented at ACR 2026

Professor Pitzalis also presented two studies at the 2026 American College of Rheumatology (ACR) meeting.

The first, presented during the Plenary I session on 8 November, looked at rosnilimab, a treatment that targets specific immune cells involved in rheumatoid arthritis. Using blood and joint tissue samples from a Phase 2B clinical trial, the researchers examined how the treatment affects immune pathways associated with the disease.

His second presentation, in the Rheumatoid Arthritis – Translational Models and Mechanisms session, examined whether the immune characteristics of joint tissue early in the disease could help predict patient outcomes five years later.

The findings add to research into how differences in the immune response within joint tissue may help explain why rheumatoid arthritis develops and progresses differently between patients.

The ACR Master designation is a significant personal recognition for Professor Pitzalis and his contribution to the field of rheumatology.

Further details of the 2026 Masters Class, including the full list of recipients, are available on The Rheumatologist website.

 

 

Back to top